Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Research and Markets: Next Generation Sequencing (NGS) Report 2013: How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/10/2013 | 04:30pm CEST

Research and Markets (http://www.researchandmarkets.com/research/ddm37b/next_generation) has announced the addition of the "Next Generation Sequencing Report 2013" report to their offering.

The Next Generation Sequencing market is poised to reach $4.4B in 2018!

How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

NGS technologies drive the way toward personalized medicine

Our analysis provides 2013-2018 market data, along with player market shares at both equipment and consumable levels. Moreover, positioning strategy of each supplier has been analyzed in the document.

Discover the NGS market's complex organization, splitted in four segments

The market segmentation is a tool used to provide a vision of the market. Based on technical and economic criteria, fours segments have been identified: research, forensics, diagnostics and consumer.

Until recently, uses of Next Generation Sequencing tools were limited to research (human whole genome, exome, small genome, targeted, transcriptome, RNA profiling, chIP-Seq, metagenomics).

Nowadays, NGS technologies have found applications mainly in two fields: clinical diagnostics and forensics.

Our investigation describes both current and future applications.

Next Generation Sequencing technologies overview

  • In April 2003, human genome project was declared complete. This first human genome sequencing took 13 years, mobilized 20000 researchers and cost $3B!
  • Since the early 2000s, sequencing technologies have come a long way from Sanger sequencing (also called 1st generation sequencing) used for the human genome project to the Next Generation Sequencing technologies available today.
  • By sequencing a large number of DNA molecules in parallel after PCR amplification, technology developers have been able to sharply increase machine throughput by a factor of 10, along with a steep price reduction.
  • The launch of a new detection method based on electrochemical detections was also a huge step forward for the sequencing world.
  • Today, based on these new technologies, we can sequence the whole human genome in less than three hours with one laboratory technician and a total cost around $1000.
  • Technologies under development are poised to extend the boundaries with a targeted sequencing cost of $100.
  • All technologies currently in use and those under development are presented in our report. Benchmarking is also presented for eight different sequencing applications.

New opportunities arise for cartridge makers

  • The wide adoption of NGS technology has changed the way NGS suppliers are generating revenue. A shift occurred in the sales mix, moving from instruments to consumables which have a higher gross margin than instruments.
  • This leads to an increase in revenue based on consumable sales.
  • The number of NGS Platforms used worldwide will exploded in the next several years and the run time will continue to decrease. Therefore, the market of NGS consumables will follow.

Report's key features

- 2013-2018 Next Generation Sequencing equipment market

- 2013-2018 Next Generation Sequencing consumable market

- Market segmentation which highlights current and future applications

- Overview of sequencing technologies and cartridges associated

- Detailed supply chain and business model analysis highlighting the major changes expected over next few years

- Company profiles of the main players

Report objectives

- Provide an overview of global NGS market both at equipment and consumable levels.

- Present main players and technologies involved

- Analyze both technical and market trends

- Focus on microfluidic consumable cartridges used for genome testing

- Supply Chain analysis

Key Topics Covered:

1. Executive summary

2. Introduction

3. Market data

4. Market segmentation

5. Next Generation Sequencing technologies overview

6. Value chain and supply chain

7. Market trends and challenges

8. Company profiles

Companies Mentioned

- 23andme

- Affymetrix

- Azco Biotech Inc

- Baseclear

- Base 4

- BGI-Shenzhen

- Completegenomics

- DNAvision

- Genia Technologies

- Genapsys

- GnuBIO

- Hitachi

- Illumina

- LaserGen

- NabSys

- Noblegen Biosciences

- Oxford Nanopore Technologies

- Pacific Biosciences

- Qiagen

- Roche 454

- Stratos Genomics Inc.

- Thermo Fisher Scientific

- TSMC

For more information visit http://www.researchandmarkets.com/research/ddm37b/next_generation

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
11:22a DGAP-NEWS : AURELIUS veröffentlicht Geschäftsbericht 2016
11:22a DGAP-NEWS : SINGULUS TECHNOLOGIES Reports Successful Final Acceptance Test (FAT) of Processing Systems for Heterojunction Solar Cells
11:22a DGAP-NEWS : AURELIUS publishes its 2016 annual report
11:21a TOP NEWS : On 'Brexit Day', EU Blocks Merger Of LSE And Deutsche Boerse
11:21a Weak sterling supports FTSE ahead of Brexit trigger, mid caps struggle
11:21a REDEYE :  Transition period in myTaste
11:21aDJDEUTSCHE BOERSE : RECOMMENDED ALL-SHARE MERGER BETWEEN DEUTSCHE BÖRSE AG AND LONDON STOCK EXCHANGE GROUP PLC - European Commission Prohibits Recommended All-Share Merger Between Deutsche Boerse AG And London Stock Exchange Group Plc
11:20a CENTAUR MEDIA : Shares Down On Expectations Of Profit Reduction
11:19a Deutsche Boerse, LSE merger plans rejected by EU regulators
11:19a AT&T : GOP Guts Internet Privacy Rules
Latest news
Advertisement
Hot News 
1.00%ConvaTec's majority investors raise $1.2 billion via stake sale
-5.58%FLYBE : cuts capacity and costs amid weak demand, pricing pressure
3.81%UK's Stagecoach confirms profit target, rail revenue rises
2.51%European shares inch higher as Brexit divorce process set to begin
8.11%HARDIDE : Shares Rise on Airbus Supplier Approval
Most Read News
03/28 SAMSUNG ELECTRONICS : With new phone due, Samsung dials down on safety message
03:46a TOSHIBA : says Westinghouse had $9.8 billion in liabilities as of end December
04:56a Toshiba's Westinghouse files for bankruptcy as charges jump
03/28 Tesla deal boosts Chinese presence in U.S. auto tech
03/28 WELLS FARGO : to pay $110 million to settle lawsuit over account abuses
Most recommended articles
03/27 Dollar hits four-month low as Trump trade deflates
05:17a EURONEXT : Deutsche Boerse, LSE merger plans rejected by EU regulators
05:14a GOLDMAN SACHS : reassures staff over Brexit in voicemail
05:11aDJLI & FUNG : 2016 Net Profit Falls 47% to $223 Million
05:11aDJSHIMAO PROPERTY : 2016 Net Profit CNY5.17 Billion